Which candidates are pro-life?
Pledge 2000 www.rnclife.org

SUBSCRIBE ME!
Get on our e-mail list!
Aug. 30, 2002
Women's Health at Risk Petition Demands the FDA Withdraw Approval of RU-486 
Concerned Women For America made the following announcement in a press release issued on August 21, 2002:  
Concerned Women for America, the American Association of Pro-Life Obstetricians and Gynecologists, and the Christian Medical Association filed a Citizen Petition on August 20 with the Food & Drug Administration requesting that the FDA immediately revoke its approval of the drug RU-486, the abortion pill. The petition is based on evidence that the FDA approved the drug in violation of its own regulations and evidence that RU-486 is severely harming American women.

Sandy Rios, president of Concerned Women for America, stated, "Whether people are pro-life or pro-choice, the blatantly indefensible approval of RU-486 by the FDA has resulted in harm to women, and in some cases death. The FDA's unprecedented action of approving a drug in violation of its own regulations has endangered the lives of American women for the sake of political expediency.

In the course of its approval of RU-486 (Mifeprex), the FDA failed to carry out its mission of ensuring that only drugs shown to be safe and effective are approved for marketing. The Citizen Petition is the result of a 22-month investigation, which included combing through 8,000 documents released by the FDA. The Petition details numerous violations of the agency's standards and rules, and reports medical complications suffered by women who took RU-486.

Donna J. Harrison, M.D., chairperson, Subcommittee on Mifeprex, American Association of Prolife Obstetricians and Gynecologists, stated, "As physicians who care about the life and health of the mother, as well as her unborn baby, the American Association of Pro-Life Obstetricians and Gynecologists has carefully reviewed RU-486 and found it to be dangerous. The recent deaths in Canada and the United States during RU-486 abortions support our findings. To safeguard the health of American women, this drug must be removed from the market."

For more information, contact CWA's Rebecca Riggs at 202/488-7000, ext. 126, or visit    http://www.cwfa.org.


ABC/Link Message to Reach Komen “Race for the Cure” in Colorado 
Participants in the Avon Breast Cancer Walk and the Susan G. Komen Race for the Cure in Colorado will have an unusual message driving past them during their 2002 events.

Last year, Colorado Right to Life joined forces with Survivors, a group of American teens who carry the message that 1/3 of their generation has been destroyed by “choice,” to launch a mobile billboard which said Breast Cancer’s Most Avoidable Risk: Abortion. The billboard, a product of Wheels America Advertising (http://www.wheelsamerica.com), was driven past hundreds of women who paid a fee to the Komen Foundation to participate in the race. At the same time, Survivors and other volunteers distributed over 2,000 brochures from the Coalition on Abortion/Breast Cancer (http://www.abortionbreastcancer.com). The coalition’s web address was also displayed on the mobile billboard.

Particularly disturbed by the Komen Foundation’s funding of Planned Parenthood in Colorado — an obvious conflict of interest — CRLC was inspired to find a way to carry the truth to the women, whom the media have effectively kept in the dark for years.

As a result, a tremendous number of women were exposed to the truth. For more information, contact Leslie Hanks at Colorado Right to Life – 303/753-9394.


Republican National
Coalition for Life


Join us on Facebook!
If you would like to make a contribution to support our work, please send your donation to:
RNC/Life - P.O. Box 618 - Alton, IL 62002 
Or you may charge your contribution
on Master Card or Visa by calling 618/462-5415.  
(Contributions are not tax-deductible)

Thank you very much for your support!

You can help!

Republican National Coalition for Life    Box 618    Alton    Illinois 62002
618-462-5415    Fax: 618-462-8909    E-mail